Lutz Beckert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lutz Beckert has a total of 215 co-authors. Here are the top co-authors by number of shared publications:
Maureen P. Swanney
Respiratory Physiology Laboratory Christchurch Hospital Christchurch New Zealand
6 shared publications- Cameron Lacey
University of Otago
5 shared publications Chris Frampton
Department of Medicine University of Otago Christchurch New Zealand
5 shared publications- Matthew J. Peters
Asbestos Dust Diseases Research Institute (ADDRI), Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2113, Australia
5 shared publications Paul T. Kelly
Sleep Unit, Christchurch Hospital, Christchurch, New Zealand
5 shared publications- Tania Huria
Māori and Indigenous Health Institute, University of Otago Christchurch, 2 Riccarton Ave, Christchurch, 8140, New Zealand.
5 shared publications
Latest Publications
- 15 February 2026
- Published by Wiley in Respirology
- Vol. 31 (3) , 321-322
Reply to ‘The Oxygenation Benefits Provided by High‐Flow Nasal Oxygen in Bronchoscopy May be Underestimated’
- 15 February 2026
- Published by Wiley in Respirology
- Vol. 31 (3) , 321-322
Reply to ‘The Oxygenation Benefits Provided by High‐Flow Nasal Oxygen in Bronchoscopy May be Underestimated’
- Open Access
- 15 June 2025
- Published by Wiley in Medical Education
- Vol. 59 (11) , 1252-1253
Beyond the ‘tick‐box’: Redesigning a course review process that fosters dialogue and exchange of ideas
- 15 June 2025
- Published by Wiley in Medical Education
- Vol. 59 (11) , 1252-1253
Open AccessBeyond the ‘tick‐box’: Redesigning a course review process that fosters dialogue and exchange of ideas
- Open Access
- 21 May 2025
- Published by Wiley in Respirology
- Vol. 30 (10) , 970-978
High Flow Nasal Oxygen and Low Flow Oxygen Are Equally Effective in Providing Oxygenation During Bronchoscopy Under Conscious Sedation: A Randomised Controlled Trial
Background and Objective: Oxygen desaturations and hypoxaemia are common during bronchoscopy despite the use of conventional low flow oxygen (LFO). Some researchers suggest high flow nasal oxygen (HFNO) may improve oxygenation in patients undergoing bronchoscopy; however, trials have varied widely in their methodology and patient population. Evidence of use in a broad patient cohort and assessment of other important considerations, including clinician/patient satisfaction, is lacking.We hypothesised that HFNO during bronchoscopy and EBUS would reduce desaturations/hypoxaemia, oxygen titrations, respiratory rate, and cough frequency when compared to LFO. We also explored clinician and patient satisfaction.Methods: Participants undergoing diagnostic bronchoscopy or EBUS with conscious sedation were randomised to receive LFO or HFNO. Data was collected via physiological monitoring devices, health records, and clinician/patient questions. The primary outcome was time spent with SpO2 < 90%.Results: A total of 121 participants were included. There was no difference in oxygenation and desaturations between LFO (n = 61) and HFNO (n = 60) in all procedures. This was also observed within the separate strata of bronchoscopy (n = 75) and EBUS (n = 46). HFNO reduced the respiratory rate in EBUS procedures (p < 0.05). The clinician satisfaction score was higher with HFNO in bronchoscopy procedures (p < 0.05). The requirement for oxygen titrations was lower with HFNO, but this did not reach statistical significance. There was no difference in cough frequency.Conclusion: LFO and HFNO were equally effective in maintaining oxygenation during bronchoscopy and EBUS in our population. HFNO had higher clinician satisfaction during bronchoscopy and may have a physiological advantage during EBUS as demonstrated by a lower respiratory rate. Trial Registration: ANZCTRN12623001262695 image
- 21 May 2025
- Published by Wiley in Respirology
- Vol. 30 (10) , 970-978
Open AccessHigh Flow Nasal Oxygen and Low Flow Oxygen Are Equally Effective in Providing Oxygenation During Bronchoscopy Under Conscious Sedation: A Randomised Controlled Trial
Background and Objective: Oxygen desaturations and hypoxaemia are common during bronchoscopy despite the use of conventional low flow oxygen (LFO). Some researchers suggest high flow nasal oxygen (HFNO) may improve oxygenation in patients undergoing bronchoscopy; however, trials have varied widely in their methodology and patient population. Evidence of use in a broad patient cohort and assessment of other important considerations, including clinician/patient satisfaction, is lacking.We hypothesised that HFNO during bronchoscopy and EBUS would reduce desaturations/hypoxaemia, oxygen titrations, respiratory rate, and cough frequency when compared to LFO. We also explored clinician and patient satisfaction.Methods: Participants undergoing diagnostic bronchoscopy or EBUS with conscious sedation were randomised to receive LFO or HFNO. Data was collected via physiological monitoring devices, health records, and clinician/patient questions. The primary outcome was time spent with SpO2 < 90%.Results: A total of 121 participants were included. There was no difference in oxygenation and desaturations between LFO (n = 61) and HFNO (n = 60) in all procedures. This was also observed within the separate strata of bronchoscopy (n = 75) and EBUS (n = 46). HFNO reduced the respiratory rate in EBUS procedures (p < 0.05). The clinician satisfaction score was higher with HFNO in bronchoscopy procedures (p < 0.05). The requirement for oxygen titrations was lower with HFNO, but this did not reach statistical significance. There was no difference in cough frequency.Conclusion: LFO and HFNO were equally effective in maintaining oxygenation during bronchoscopy and EBUS in our population. HFNO had higher clinician satisfaction during bronchoscopy and may have a physiological advantage during EBUS as demonstrated by a lower respiratory rate. Trial Registration: ANZCTRN12623001262695 image
- Open Access
- 15 April 2025
- Published by Wiley in Internal Medicine Journal
- Vol. 55 (7) , 1161-1168
Incidence, prevalence and mortality of rheumatoid arthritis in Canterbury, Aotearoa New Zealand
Background: There is relatively little research regarding the frequency of rheumatoid arthritis (RA) in Canterbury and no previous studies comparing the mortality of RA in Aotearoa New Zealand to a general population.Aims: To determine the incidence, prevalence and mortality of RA in Canterbury, Aotearoa New Zealand.Methods: Clinical records of persons attending the Christchurch Hospital rheumatology service between 1 January 2006 and 31 December 2008 (Period 1) and between 1 January 2011 and 31 December 2013 (Period 2) were reviewed to identify individuals who met the 2010 American College of Rheumatology/European League Against Rheumatism RA classification criteria. Medical records for persons treated by private sector rheumatologists were also reviewed. The period prevalence and average annual incidence for each time period were calculated. Prevalence and incidence rates for the total population were age‐ and sex‐adjusted based on the usually resident population from the 2013 national Census. Standardised mortality ratios (SMRs) compared to the general population were calculated.Results: The annual incidence was 24.40 per 100 000 (95% confidence interval (CI): 21.36–27.43) for Period 1 and 22.06 per 100 000 (95% CI: 19.32–24.81) for Period 2. The period prevalence was 442.65 per 100 000 (95% CI: 420.08–465.04) for Period 1 and 448.66 per 100 000 (95% CI: 427.31–470.01) for Period 2. The all‐cause SMR for individuals with incident RA was 1.25 (95% CI: 0.95–1.60). The SMR for all prevalent RA during Period 1 was 2.01 (95% CI: 1.85–2.19) and for Period 2 was 1.87 (95% CI: 1.69–2.06).Conclusions: The frequency of RA in the Canterbury population is comparable to other regions. Mortality for all individuals with prevalent RA was approximately two times higher than the general population.
- 15 April 2025
- Published by Wiley in Internal Medicine Journal
- Vol. 55 (7) , 1161-1168
Open AccessIncidence, prevalence and mortality of rheumatoid arthritis in Canterbury, Aotearoa New Zealand
Background: There is relatively little research regarding the frequency of rheumatoid arthritis (RA) in Canterbury and no previous studies comparing the mortality of RA in Aotearoa New Zealand to a general population.Aims: To determine the incidence, prevalence and mortality of RA in Canterbury, Aotearoa New Zealand.Methods: Clinical records of persons attending the Christchurch Hospital rheumatology service between 1 January 2006 and 31 December 2008 (Period 1) and between 1 January 2011 and 31 December 2013 (Period 2) were reviewed to identify individuals who met the 2010 American College of Rheumatology/European League Against Rheumatism RA classification criteria. Medical records for persons treated by private sector rheumatologists were also reviewed. The period prevalence and average annual incidence for each time period were calculated. Prevalence and incidence rates for the total population were age‐ and sex‐adjusted based on the usually resident population from the 2013 national Census. Standardised mortality ratios (SMRs) compared to the general population were calculated.Results: The annual incidence was 24.40 per 100 000 (95% confidence interval (CI): 21.36–27.43) for Period 1 and 22.06 per 100 000 (95% CI: 19.32–24.81) for Period 2. The period prevalence was 442.65 per 100 000 (95% CI: 420.08–465.04) for Period 1 and 448.66 per 100 000 (95% CI: 427.31–470.01) for Period 2. The all‐cause SMR for individuals with incident RA was 1.25 (95% CI: 0.95–1.60). The SMR for all prevalent RA during Period 1 was 2.01 (95% CI: 1.85–2.19) and for Period 2 was 1.87 (95% CI: 1.69–2.06).Conclusions: The frequency of RA in the Canterbury population is comparable to other regions. Mortality for all individuals with prevalent RA was approximately two times higher than the general population.
- Open Access
- 28 October 2024
- Published by Wiley in Respirology
- Vol. 29 (12) , 1023-1046
Diagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand
Hypersensitivity pneumonitis (HP) is an immune‐mediated interstitial lung disease (ILD) relating to specific occupational, environmental or medication exposures. Disease behaviour is influenced by the nature of exposure and the host response, with varying degrees of lung inflammation and fibrosis seen within individuals. The differentiation of HP from other ILDs is important due to distinct causes, pathophysiology, prognosis and management implications. This Thoracic Society of Australia and New Zealand (TSANZ) position statement aims to provide an up‐to‐date summary of the evidence for clinicians relating to the diagnosis and management of HP in adults, in the Australian and New Zealand context. This document highlights recent relevant findings and gaps in the literature for which further research is required. image
- 28 October 2024
- Published by Wiley in Respirology
- Vol. 29 (12) , 1023-1046
Open AccessDiagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand
Hypersensitivity pneumonitis (HP) is an immune‐mediated interstitial lung disease (ILD) relating to specific occupational, environmental or medication exposures. Disease behaviour is influenced by the nature of exposure and the host response, with varying degrees of lung inflammation and fibrosis seen within individuals. The differentiation of HP from other ILDs is important due to distinct causes, pathophysiology, prognosis and management implications. This Thoracic Society of Australia and New Zealand (TSANZ) position statement aims to provide an up‐to‐date summary of the evidence for clinicians relating to the diagnosis and management of HP in adults, in the Australian and New Zealand context. This document highlights recent relevant findings and gaps in the literature for which further research is required. image
- 8 May 2024
- Published by Springer Nature in Sleep and Breathing
- Vol. 28 (4) , 1609-1616
Cerebral perfusion is not impaired in persons with moderate obstructive sleep apnoea when awake
Purpose It is well established that, together with a multitude of other adverse effects on health, severe obstructive sleep apnoea causes reduced cerebral perfusion and, in turn, reduced cerebral function. Less clear is the impact of moderate obstructive sleep apnoea (OSA). Our aim was to determine if cerebral blood flow is impaired in people diagnosed with moderate OSA. Methods Twenty-four patients diagnosed with moderate OSA (15 ≤ apnoea-hypopnea index (AHI) < 30) were recruited (aged 32–72, median 59 years, 10 female). Seven controls (aged 42–73 years, median 62 years, 4 female) with an AHI < 5 were also recruited. The OSA status of all participants was confirmed at baseline by unattended polysomnography and they had an MRI arterial-spin-labelling scan of cerebral perfusion. Results Neither global perfusion nor voxel-wise perfusion differed significantly between the moderate-OSA and control groups. We also compared the average perfusion across three regional clusters, which had been found in a previous study to have significant perfusion differences with moderate-severe OSA versus control, and found no significant difference in perfusion between the two groups. The perfusions were also very close, with means of 50.2 and 51.8 mL/100 g/min for the moderate-OSAs and controls, respectively, with a negligible effect size (Cohen’s d = 0.10). Conclusion We conclude that cerebral perfusion is not impaired in people with moderate OSA and that cerebral flow regulatory mechanisms can cope with the adverse effects which occur in moderate OSA. This is an important factor in clinical decisions for prescription of continuous positive airway pressure therapy (CPAP).
- 8 May 2024
- Published by Springer Nature in Sleep and Breathing
- Vol. 28 (4) , 1609-1616
Cerebral perfusion is not impaired in persons with moderate obstructive sleep apnoea when awake
Purpose It is well established that, together with a multitude of other adverse effects on health, severe obstructive sleep apnoea causes reduced cerebral perfusion and, in turn, reduced cerebral function. Less clear is the impact of moderate obstructive sleep apnoea (OSA). Our aim was to determine if cerebral blood flow is impaired in people diagnosed with moderate OSA. Methods Twenty-four patients diagnosed with moderate OSA (15 ≤ apnoea-hypopnea index (AHI) < 30) were recruited (aged 32–72, median 59 years, 10 female). Seven controls (aged 42–73 years, median 62 years, 4 female) with an AHI < 5 were also recruited. The OSA status of all participants was confirmed at baseline by unattended polysomnography and they had an MRI arterial-spin-labelling scan of cerebral perfusion. Results Neither global perfusion nor voxel-wise perfusion differed significantly between the moderate-OSA and control groups. We also compared the average perfusion across three regional clusters, which had been found in a previous study to have significant perfusion differences with moderate-severe OSA versus control, and found no significant difference in perfusion between the two groups. The perfusions were also very close, with means of 50.2 and 51.8 mL/100 g/min for the moderate-OSAs and controls, respectively, with a negligible effect size (Cohen’s d = 0.10). Conclusion We conclude that cerebral perfusion is not impaired in people with moderate OSA and that cerebral flow regulatory mechanisms can cope with the adverse effects which occur in moderate OSA. This is an important factor in clinical decisions for prescription of continuous positive airway pressure therapy (CPAP).
- Open Access
- 18 February 2024
- Published by Taylor & Francis in Behavioral Sleep Medicine
- Vol. 22 (4) , 516-529
Reasons for why Medical Students Prefer Specific Sleep Management Strategies
Insomnia symptoms are common among medical students. This study explored the perspectives of medical students about which sleep management strategies to use. Medical students responded to an online survey on their thoughts about the use of various sleep management strategies. Of the 828 respondents, 568 (69%) provided responses to questions about the most preferred strategies and 450 (54%) provided responses about their least preferred strategies. About 48.5% felt their insomnia symptoms were too mild to see a clinician and 23.9% did not think their symptoms warranted sleep medication. Over 40% of students could not avoid work before sleep, have consistent sleep/wake times, or engage in regular exercise because of their busy and inconsistent schedules. Approximately 40-60% could not improve their sleep environment (e.g. better heating and bed) because of the associated costs. Over 80% reported an inability to change their pre-sleep habits (e.g. using electronics close to bedtime, using bed for activities other than sleep or sex). Half of the students disliked relaxation techniques or felt they would not help. Around 30-50% did not believe that changing caffeine and/or alcohol intake would affect their sleep. Medical students may benefit from additional sleep education. Clinicians may need to discuss which strategies individual students prefer and modify their recommendations accordingly.
- 18 February 2024
- Published by Taylor & Francis in Behavioral Sleep Medicine
- Vol. 22 (4) , 516-529
Open AccessReasons for why Medical Students Prefer Specific Sleep Management Strategies
Insomnia symptoms are common among medical students. This study explored the perspectives of medical students about which sleep management strategies to use. Medical students responded to an online survey on their thoughts about the use of various sleep management strategies. Of the 828 respondents, 568 (69%) provided responses to questions about the most preferred strategies and 450 (54%) provided responses about their least preferred strategies. About 48.5% felt their insomnia symptoms were too mild to see a clinician and 23.9% did not think their symptoms warranted sleep medication. Over 40% of students could not avoid work before sleep, have consistent sleep/wake times, or engage in regular exercise because of their busy and inconsistent schedules. Approximately 40-60% could not improve their sleep environment (e.g. better heating and bed) because of the associated costs. Over 80% reported an inability to change their pre-sleep habits (e.g. using electronics close to bedtime, using bed for activities other than sleep or sex). Half of the students disliked relaxation techniques or felt they would not help. Around 30-50% did not believe that changing caffeine and/or alcohol intake would affect their sleep. Medical students may benefit from additional sleep education. Clinicians may need to discuss which strategies individual students prefer and modify their recommendations accordingly.
- Open Access
- 9 December 2023
- Published by Wiley in Respirology Case Reports
- Vol. 12 (1) , e01265
Scimitar syndrome, bronchiectasis, haemoptysis and a pneumonectomy
Scimitar syndrome is a rare condition characterized by partial or complete anomalous pulmonary venous drainage of the lung to the inferior vena cava, right lung hypoplasia and dextroposition of the heart. Haemoptysis is uncommon in adults, although the clinical spectrum is wide. We report a case of a 38‐year‐old male with scimitar syndrome who had low grade haemoptysis persisting over several years secondary to bronchiectatic changes in his hypoplastic right lung. Conservative measures to manage haemoptysis were unsuccessful and the patient proceeded to bronchial artery embolization. The post‐procedure course was complicated by lung infarction and the patient ultimately required pneumonectomy. Deformities of the blood vessels and lungs are complex in scimitar syndrome. Bronchial artery embolization should be approached cautiously to protect pulmonary perfusion.
- 9 December 2023
- Published by Wiley in Respirology Case Reports
- Vol. 12 (1) , e01265
Open AccessScimitar syndrome, bronchiectasis, haemoptysis and a pneumonectomy
Scimitar syndrome is a rare condition characterized by partial or complete anomalous pulmonary venous drainage of the lung to the inferior vena cava, right lung hypoplasia and dextroposition of the heart. Haemoptysis is uncommon in adults, although the clinical spectrum is wide. We report a case of a 38‐year‐old male with scimitar syndrome who had low grade haemoptysis persisting over several years secondary to bronchiectatic changes in his hypoplastic right lung. Conservative measures to manage haemoptysis were unsuccessful and the patient proceeded to bronchial artery embolization. The post‐procedure course was complicated by lung infarction and the patient ultimately required pneumonectomy. Deformities of the blood vessels and lungs are complex in scimitar syndrome. Bronchial artery embolization should be approached cautiously to protect pulmonary perfusion.
- Open Access
- 8 August 2023
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 23 (3) , 3
Stakeholders’ Perspectives on the Quality of End-of-Life Health Care Services for Chronic Obstructive Airways Disease: A Focus Group Study
Delivery of end-of-life care for severe chronic obstructive pulmonary disease (COPD) has been hampered by an unpredictable disease trajectory and poor integration of health care and social services. To critically explore the perspectives, values, and experiences of stakeholders in COPD end-of-life healthcare services in a large district in Aotearoa New Zealand. Focus groups analysed utilising critical theory and Actor-Network Theory. Stakeholders in end-of-life COPD healthcare services were purposively sampled from a large healthcare network in Canterbury, Aotearoa New Zealand to participate in seven focus groups (bereaved carers, community-based health professionals, non-Māori, non-Pacific patients, and support people (two groups), Māori patients, supporters and health professionals, Pacific patients, support people and health professionals, and hospital-based health professionals). Participants discussed end-of-life care services for people with COPD. Transcripts were coded utilising descriptive and structural coding to develop themes related to provision of quality care. Participants were positioned as experts. We considered how the themes arising supported and disrupted the healthcare network for end-of-life COPD. Five themes related to quality of care for end-of-life COPD were identified: compassion, competence, community, commitment, and collaboration. The absence of any of these five themes required for quality care led to power imbalances within healthcare systems. Power inequities created disconnection among stakeholders which then disrupted commitment, community, and collaboration. A dysfunctional healthcare network impeded compassion between stakeholders and did not support their competence, leading to lower quality care. All five themes were identified as essential to delivery of high-quality end-of-life care in COPD. Stakeholders’ perspectives of end-of-life care for COPD identified of core features of a health system network that enabled or impeded the actions of stakeholders and allocation of resources to provide quality care.
- 8 August 2023
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 23 (3) , 3
Open AccessStakeholders’ Perspectives on the Quality of End-of-Life Health Care Services for Chronic Obstructive Airways Disease: A Focus Group Study
Delivery of end-of-life care for severe chronic obstructive pulmonary disease (COPD) has been hampered by an unpredictable disease trajectory and poor integration of health care and social services. To critically explore the perspectives, values, and experiences of stakeholders in COPD end-of-life healthcare services in a large district in Aotearoa New Zealand. Focus groups analysed utilising critical theory and Actor-Network Theory. Stakeholders in end-of-life COPD healthcare services were purposively sampled from a large healthcare network in Canterbury, Aotearoa New Zealand to participate in seven focus groups (bereaved carers, community-based health professionals, non-Māori, non-Pacific patients, and support people (two groups), Māori patients, supporters and health professionals, Pacific patients, support people and health professionals, and hospital-based health professionals). Participants discussed end-of-life care services for people with COPD. Transcripts were coded utilising descriptive and structural coding to develop themes related to provision of quality care. Participants were positioned as experts. We considered how the themes arising supported and disrupted the healthcare network for end-of-life COPD. Five themes related to quality of care for end-of-life COPD were identified: compassion, competence, community, commitment, and collaboration. The absence of any of these five themes required for quality care led to power imbalances within healthcare systems. Power inequities created disconnection among stakeholders which then disrupted commitment, community, and collaboration. A dysfunctional healthcare network impeded compassion between stakeholders and did not support their competence, leading to lower quality care. All five themes were identified as essential to delivery of high-quality end-of-life care in COPD. Stakeholders’ perspectives of end-of-life care for COPD identified of core features of a health system network that enabled or impeded the actions of stakeholders and allocation of resources to provide quality care.
- 30 September 2022
- Published by Taylor & Francis in Behavioral Sleep Medicine
- Vol. 21 (4) , 448-459
Sleep Management Strategies Among Medical Students At the University of Otago
We aim to investigate factors which might affect the sleep of medical students, and how they currently manage their sleep.An online survey was sent to medical students at the University of Otago.Af...
- 30 September 2022
- Published by Taylor & Francis in Behavioral Sleep Medicine
- Vol. 21 (4) , 448-459
Sleep Management Strategies Among Medical Students At the University of Otago
We aim to investigate factors which might affect the sleep of medical students, and how they currently manage their sleep.An online survey was sent to medical students at the University of Otago.Af...